Arrowpoint Investment Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56M Buy
+5,293
New +$1.4M 0.56% 36
2025
Q4
Sell
-17,382
Closed -$3.4M 153
2025
Q3
$3.4M Buy
+17,382
New +$2.86M 3.4% 7
2025
Q2
Sell
-3,260
Closed -$195K 909
2025
Q1
$195K Buy
3,260
+1,860
+133% +$172K 0.02% 718
2024
Q4
$185K Buy
+1,400
New +$131K 0.04% 418

Other funds holding ALAB

Arrowpoint Investment Partners's ALAB Position: Q2 2026 in Review

Arrowpoint Investment Partners opened a new position in Astera Labs (ALAB) in Q2 2026: 5,293 shares worth $2.56M. The stake represents 0.56% of the portfolio and ranks #36 among its holdings. This is a return to the name: Arrowpoint Investment Partners previously reported a position in ALAB as recently as Q3 2025.

Arrowpoint Investment Partners first reported a position in ALAB in Q4 2024 and has held it in 4 quarters since. The position peaked at $3.4M in Q3 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Arrowpoint Investment Partners held 5,293 shares of Astera Labs worth $2.56M as of Q2 2026.
  • Astera Labs was a new Arrowpoint Investment Partners position in Q2 2026.
  • Astera Labs made up 0.56% of Arrowpoint Investment Partners's portfolio in Q2 2026, its #36 holding.
  • Arrowpoint Investment Partners first reported a position in Astera Labs in Q4 2024 and has held it in 4 quarters since.
  • Arrowpoint Investment Partners's Astera Labs position peaked at $3.4M in Q3 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.